Karuna Therapeutics Inc.

NASDAQ: KRTX · Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM

Karuna Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-26.97 -22.49 -26.54
PEG Ratio
-0.79 -0.29 -0.29
PS Ratio
17.89K 584.29 103.27
PB Ratio
9.33 5.52 7.60
P/FCF Ratio
-30.09 -27.15 -36.72
P/OCF Ratio
-30.32 -27.26 -37.84
OCF/S Ratio
-589.94 -21.44 -2.73
Debt / Equity Ratio
0.01 0.00 0.01
Quick Ratio
18.82 33.18 24.56
Current Ratio
19.31 34.02 25.59
Asset Turnover
0.00 0.01 0.07
Interest Coverage
n/a -20.43 n/a
Return on Equity
-0.35 -0.25 -0.29
Return on Assets
-0.32 -0.24 -0.27
Return on Invested Capital
-0.39 -0.26 -0.28
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
-1.6 0.90 0.99
Net Profit Margin
-663.12 -25.98 -3.89
Pretax Profit Margin
-662.09 -25.85 -3.89
Operating Profit Margin
-756.54 -27.23 -3.89
FCF Margin
n/a n/a n/a
EBITDA Margin
-753.94 -27.23 -3.87